Simultaneous quantitation of zidovudine, efavirenz, lopinavir and ritonavir in human hair by liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.
暂无分享,去创建一个
Zhiyong Shen | Xiaomin Li | Yan Wu | Liuxi Chu | Haoran Yang | Huihua Deng | Cailing Duan | Jin Yang | Ying Xie | Quan Zhang | Shanhai Qiao
[1] C. Orrell,et al. A validated liquid chromatography/tandem mass spectrometry method for the analysis of efavirenz in 0.2 mg hair samples from human immunodeficiency virus infected patients. , 2018, Rapid communications in mass spectrometry : RCM.
[2] Xiaomin Li,et al. Simultaneous determination of antiretroviral drugs in human hair with liquid chromatography-electrospray ionization-tandem mass spectrometry. , 2018, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[3] L. Nováková,et al. Current antiviral drugs and their analysis in biological materials – Part II: Antivirals against hepatitis and HIV viruses , 2018, Journal of pharmaceutical and biomedical analysis.
[4] Arindam Mukhopadhyay,et al. A LC–MS/MS method with column coupling technique for simultaneous estimation of lamivudine, zidovudine, and nevirapine in human plasma , 2016, Journal of Analytical Science and Technology.
[5] H. Xing,et al. Lamivudine Concentration in Hair and Prediction of Virologic Failure and Drug Resistance among HIV Patients Receiving Free ART in China , 2016, PloS one.
[6] Yachen Deng,et al. Rapid identification of efavirenz metabolites in rats and humans by ultra high performance liquid chromatography combined with quadrupole time-of-flight tandem mass spectrometry. , 2015, Journal of separation science.
[7] P. Bacchetti,et al. Comparing the Novel Method of Assessing PrEP Adherence/Exposure Using Hair Samples to Other Pharmacologic and Traditional Measures , 2014, Journal of acquired immune deficiency syndromes.
[8] M. Belay,et al. Adherence to Antiretroviral Therapy and associated factors among HIV infected children in Ethiopia: unannounced home-based pill count versus caregivers’ report , 2013, BMC Pediatrics.
[9] Wei Gao,et al. Simultaneous determination of hair cortisol, cortisone and DHEAS with liquid chromatography-electrospray ionization-tandem mass spectrometry in negative mode. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[10] J. Ananworanich,et al. Second-Line Protease Inhibitor-Based Haart after Failing Non-Nucleoside Reverse Transcriptase Inhibitor-Based Regimens in Asian HIV-Infected Children , 2013, Antiviral therapy.
[11] H. Rosing,et al. Development and validation of an assay for the simultaneous determination of zidovudine, abacavir, emtricitabine, lamivudine, tenofovir and ribavirin in human plasma using liquid chromatography-tandem mass spectrometry. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[12] A. Petróczi,et al. Simultaneous analysis of antiretroviral drugs abacavir and tenofovir in human hair by liquid chromatography-tandem mass spectrometry. , 2013, Journal of pharmaceutical and biomedical analysis.
[13] R. Kronstrand,et al. Society of Hair Testing guidelines for drug testing in hair. , 2012, Forensic science international.
[14] Graeme Smith. European Medicines Agency guideline on bioanalytical method validation: what more is there to say? , 2012, Bioanalysis.
[15] D. Banji,et al. Simultaneous determination of efavirenz, lamivudine and tenofovir disoproxil fumerate in tablet dosage form by using RP-HPLC , 2012 .
[16] Lizheng Shi,et al. Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices , 2012, PharmacoEconomics.
[17] R. Greenblatt,et al. Microanalysis of the antiretroviral nevirapine in human hair from HIV-infected patients by liquid chromatography-tandem mass spectrometry , 2011, Analytical and bioanalytical chemistry.
[18] P. Reiss,et al. The Lopinavir/Ritonavir-Associated Rise in Lipids is not Related to Lopinavir or Ritonavir Plasma Concentration , 2011, Antiviral therapy.
[19] M. Ekstrand,et al. Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India. , 2011, International health.
[20] D. Cromarty,et al. Determination of salivary efavirenz by liquid chromatography coupled with tandem mass spectrometry. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[21] Lizheng Shi,et al. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis , 2010, Health and quality of life outcomes.
[22] V. Haufroid,et al. Validation and clinical application of a high performance liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the quantitative determination of 10 anti-retrovirals in human peripheral blood mononuclear cells. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[23] C. Katlama,et al. Influence of antigen exposure on the loss of long-term memory to childhood vaccines in HIV-infected patients. , 2009, Vaccine.
[24] A. Telenti,et al. A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[25] David R. Holtgrave,et al. Factors associated with adherence to highly active antiretroviral therapy in homeless or unstably housed adults living with HIV , 2009, AIDS care.
[26] Mardge H. Cohen,et al. Protease inhibitor levels in hair strongly predict virologic response to treatment , 2009, AIDS.
[27] M. Dybul,et al. Evolution of drug resistance after virological failure of a first-line highly active antiretroviral therapy regimen in Uganda , 2009, Antiviral therapy.
[28] R. Greenblatt,et al. Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.
[29] G. di Perri,et al. HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[30] B. Jung,et al. Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry. , 2007, Biomedical chromatography : BMC.
[31] Evan Wood,et al. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy , 2007, AIDS.
[32] C. Leport,et al. Hair versus plasma concentrations as indicator of indinavir exposure in HIV-1-infected patients treated with indinavir/ritonavir combination , 2007, AIDS.
[33] J. Fisher,et al. Visual Analog Scale of ART Adherence: Association With 3-Day Self-Report and Adherence Barriers , 2006, Journal of acquired immune deficiency syndromes.
[34] Hélène Budzinski,et al. Simultaneous determination of the antiretroviral agents: amprenavir, lopinavir, ritonavir, saquinavir and efavirenz in human peripheral blood mononuclear cells by high-performance liquid chromatography-mass spectrometry. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[35] R. Yogev,et al. Rapid Human Immunodeficiency Virus Decay in Highly Active Antiretroviral Therapy (HAART)-Experienced Children after Starting Mega-HAART , 2004, Journal of Virology.
[36] G. Maga,et al. HIV-1 reverse transcriptase inhibitors: current issues and future perspectives. , 2004, Current drug metabolism.
[37] M. Maurin,et al. Kinetics and Mechanism of Hydrolysis of Efavirenz , 2002, Pharmaceutical Research.
[38] W. Lambert,et al. Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid , 2003, Journal of the American Society for Mass Spectrometry.
[39] H. Sachs,et al. Proficiency test for the analysis of hair for drugs of abuse, organized by the Society of Hair Testing. , 2003, Forensic science international.
[40] A. Antinori,et al. Treatment‐Related Factors and Highly Active Antiretroviral Therapy Adherence , 2002, Journal of acquired immune deficiency syndromes.
[41] R. Greenblatt,et al. Hair It Is: The Long and Short of Monitoring Antiretroviral Treatment , 2002, Annals of Internal Medicine.
[42] M. Eberlin,et al. Atmospheric pressure photoionization mass spectrometry. Ionization mechanism and the effect of solvent on the ionization of naphthalenes. , 2002, Analytical chemistry.
[43] Risto Kostiainen,et al. Liquid chromatography/mass spectrometry in anabolic steroid analysis--optimization and comparison of three ionization techniques: electrospray ionization, atmospheric pressure chemical ionization and atmospheric pressure photoionization. , 2002, Journal of mass spectrometry : JMS.
[44] J. Smeraglia,et al. Matrix effects and selectivity issues in LC-MS-MS , 2002 .
[45] A. Wu,et al. Self‐Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection , 2001, Journal of acquired immune deficiency syndromes.
[46] J. Dunn,et al. Simultaneous determination of zidovudine and lamivudine in human serum using HPLC with tandem mass spectrometry. , 2000, Journal of pharmaceutical and biomedical analysis.
[47] Y. Nakahara. Hair analysis for abused and therapeutic drugs. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[48] C. Fletcher. Pharmacologic Considerations for Therapeutic Success with Antiretroviral Agents , 1999, The Annals of pharmacotherapy.
[49] F. Pragst,et al. Illegal and Therapeutic Drug Concentrations in Hair Segments - A Timetable of Drug Exposure? , 1998, Forensic science review.
[50] A. J. Wright,et al. Recent advances in the management of human immunodeficiency virus infection. , 1997, Mayo Clinic proceedings.
[51] S. Vella. Rationale and experience with reverse transcriptase inhibitors and protease inhibitors. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[52] L. Perrin,et al. Therapeutic interventions in primary HIV infection. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[53] B. Larder,et al. Viral resistance and the selection of antiretroviral combinations. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.